Description:
Biomarkers are biological or biochemical molecules, genetic changes, or other measurable characteristics that indicate or predict a condition, risk, or likely biological response. They have a wide range of diagnostic applications, including predicting disease risk, diagnosis, prognosis, identifying appropriate therapy, and monitoring disease or its recurrence.
Kalorama Information’s World Market for Biomarkers (Cardiac [cTn, HscTn, Others], Tumor Markers, Infectious Disease Markers, Autoimmune/Allergy Markers, Neurological Markers, C-Reactive Protein and Other Markers) provides an in-depth analysis of the global biomarker market, estimating market sizes from 2014 to 2024, with 2019 as the base year. This report offers market forecasts for the total biomarker market, segmented by application (clinical diagnostic and research biomarkers) and geographical distribution.
Key Features of the Report:
- Market Overview:
- Comprehensive analysis of the biomarker market trends, technological advancements, and key drivers.
- Discussion on the impact of an aging population, targeted therapies, and the clinical diagnostic test market.
- Market Segmentation and Forecasts (2014-2024)
Clinical Diagnostic Biomarker Market by Disease:
- Total Market Growth:
- Analysis of market growth driven by an aging population, new targeted therapies, and the clinical diagnostic test market.
- Key segments such as infectious disease and cancer biomarkers showing varied growth rates.
- Market Data (2014-2024)
Cancer Biomarker Market:
- Cancer Immunoassays:
- Detection of proteins in blood, urine, or other body fluids indicating cancer.
- Use in diagnosis, treatment monitoring, and disease recurrence.
- Market Data (2014-2024)
Infectious Disease Biomarker Market:
- Largest Disease Segment:
- Tests for antigens or nucleic acid sequences, markers of the body’s response, and antibiotic resistance genes.
- Market Data (2014-2024)
Cardiovascular Disease Biomarker Market:
- Cardiac Biomarkers:
- Substances released during heart damage or stress used to diagnose and monitor cardiovascular disease.
- Market Data (2014-2024)
Immunological Disease Biomarker Market:
- Autoimmune and Allergy:
- Diagnostic testing for autoimmune diseases and allergic responses.
- Market Data (2014-2024)
Neurological Disease Biomarker Market:
- Central and Peripheral Nervous System Disorders:
- Age-related diseases, neurodegenerative diseases, and autoimmune diseases.
- Market Data (2014-2024)
Other Diseases:
- Broad Definition of Biomarkers:
- Used for a variety of diagnostic applications across different disease types.
- Market Data (2014-2024)
C-Reactive Protein (CRP):
- High-Interest Biomarker:
- Detailed sales breakout of CRP tests.
- Market Data (2014-2024)
Market Drivers and Restraints:
- Applications Focus:
- Research and diagnostic applications of biomarkers.
- Analysis of market drivers and restraints at macro and segment levels.
Key Technologies and Companies:
- Technologies Used:
- Traditional and new technologies for biomarker discovery, detection, and analysis.
- Selected Companies:
- Profiles of key players using various technologies and commercializing biomarker tests.
Competitive Landscape:
- Company Profiles:
- Detailed profiles of companies active in biomarker discovery and commercialization.
- Focus on companies with commercialized products and advanced development programs.
For further details and to purchase directly, please contact us.
Sample Report: A sample is available as a PDF upon request.
Table: Total Global Biomarker Market, by Application, 2014-2024 (in millions $)
| Year | Clinical Diagnostic | Research | Total |
| 2014 | $XX Million | $XX Million | $XX Million |
| 2015 | $XX Million | $XX Million | $XX Million |
| 2016 | $XX Million | $XX Million | $XX Million |
| 2017 | $XX Million | $XX Million | $XX Million |
| 2018 | $XX Million | $XX Million | $XX Million |
| 2019 | $XX Million | $XX Million | $XX Million |
| 2020 | $XX Million | $XX Million | $XX Million |
| 2021 | $XX Million | $XX Million | $XX Million |
| 2022 | $XX Million | $XX Million | $XX Million |
| 2023 | $XX Million | $XX Million | $XX Million |
| 2024 | $XX Million | $XX Million | $XX Million |
| CAGR 2014-2019 | $XX Million | $XX Million | $XX Million |
| CAGR 2019-2024 | $XX Million | $XX Million | $XX Million |
| CAGR 2014-2024 | $XX Million | $XX Million | $XX Million |
Source: Kalorama Information
